Literature DB >> 6356809

Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

M B Pepys, M L Baltz.   

Abstract

The acute phase response among plasma proteins is a normal response to tissue injury and is therefore a fundamental aspect of many diverse disease processes. It probably usually has a beneficial net function in limiting damage and promoting repair but in some circumstances it may have pathological consequences. Sustained high levels of acute phase proteins and especially SAA are associated with the development of amyloidosis in some individuals. Increased concentrations of CRP may, by activating the complement system, contribute to inflammation and enhance tissue damage. Failure of the normal or appropriate CRP response may also possibly have deleterious effects. SAA is a polymorphic protein which is normally present only in trace amounts but which, during the acute phase response, becomes one of the major apolipoproteins associated with high-density lipoprotein particles. The function of apoSAA is not known but it must have considerable physiological significance apart from its role as the putative precursor of amyloid A protein fibrils. CRP and SAP have been very stably conserved throughout vertebrate evolution and homologous proteins are apparently present even in vertebrates. This strongly suggests that they have important functions although these have not yet been precisely delineated. The main role of CRP may be to provide for enhanced clearance of inappropriate materials from the plasma whether these are of extrinsic origin, such as microorganisms and their products, or the autologous products of cell damage and death. The interaction between aggregated CRP and plasma low-density lipoprotein may play a significant part in the normal function of CRP and may also have a role in lipoprotein metabolism, clearance, and deposition. SAP is a normal tissue protein as well as being a plasma protein. Aggregated SAP selectively binds fibronectin and this may represent an aspect of the normal function of SAP. The deposition of SAP in amyloid is evidently not a normal function but it is not known whether this deposition is involved in the pathogenesis of amyloid or whether it is merely an epiphenomenon. In any case immunohistochemical staining for SAP is useful in the diagnosis of amyloid, in investigation of glomerulonephritis, and in studying disorders of elastic tissue. Regardless of its physiological or pathophysiological functions, the assay of serum CRP is a valuable aid to clinical management in a number of different situations and in different diseases provided results are interpreted in the light of full clinical information.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6356809     DOI: 10.1016/s0065-2776(08)60379-x

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  304 in total

1.  Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo.

Authors:  B Weinhold; A Bader; V Poli; U Rüther
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

Review 2.  C-reactive protein: a critical update.

Authors:  Mark B Pepys; Gideon M Hirschfield
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

3.  Plasma leucocyte elastase concentrations in smokers.

Authors:  C R Hind; H Joyce; G A Tennent; M B Pepys; N B Pride
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

4.  Defective interleukin-1 production in a familial monocyte disorder with a combined abnormality of mobility and phagocytosis-killing.

Authors:  A Komiyama; M Ichikawa; H Kanda; K Aoyama; K Yasui; M Yamazaki; H Kawai; Y Miyagawa; T Akabane
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

5.  Evaluation of disease activity in rheumatic patients by leucocyte adhesiveness/aggregation.

Authors:  S Berliner; M Fried; D Caspi; A Weinberger; M Yaron; J Pinkhas; M Aronson
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

6.  C-reactive protein-mediated complement activation in polymyalgia rheumatica and other systemic inflammatory diseases.

Authors:  P Vaith; G M Hänsch; H H Peter
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

7.  Mouse serum amyloid P-component (SAP) levels controlled by a locus on chromosome 1.

Authors:  R F Mortensen; P T Le; B A Taylor
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

8.  Examining the etiology of early-onset breast cancer in the Canadian Partnership for Tomorrow's Health (CanPath).

Authors:  Joy Pader; Robert B Basmadjian; Dylan E O'Sullivan; Nicole E Mealey; Yibing Ruan; Christine Friedenreich; Rachel Murphy; Edwin Wang; May Lynn Quan; Darren R Brenner
Journal:  Cancer Causes Control       Date:  2021-06-25       Impact factor: 2.506

9.  Kinetics of C-reactive protein in acute viral hepatitis.

Authors:  Y Atono; M Sata; K Tanikawa
Journal:  Gastroenterol Jpn       Date:  1989-12

10.  C reactive protein concentrations during long distance running.

Authors:  A F Strachan; T D Noakes; G Kotzenberg; A E Nel; F C de Beer
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.